Internal Medicine · Los Angeles, CA
NPI
1255359840
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4645 Hollywood Blvd, Suite 4
Los Angeles, CA, 90027
Phone (323) 661-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
4,889 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$3.0M
29,267 prescriptions
Company payments, 2025
$1,544
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Missak Kltchian was code 99490 (chronic, principal, and transitional care management), 1,985 times for 266 patients. In total Missak Kltchian billed 4,889 services in 21 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,985 | 266 | $46.13 | $92K |
| 99213 Office E&M - Established | Office | 1,020 | 357 | $65.49 | $67K |
| 36415 Venipuncture Blood Collection | Office | 379 | 260 | $8.65 | $3,278 |
| 93000 Electrocardiogram | Office | 288 | 249 | $10.01 | $2,883 |
| 99497 Care Management/Coordination | Office | 233 | 231 | $61.17 | $14K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 179 | 179 | $140.00 | $25K |
| G0008 Administration of influenza virus vaccine | Office | 146 | 141 | $35.02 | $5,113 |
| 90694 Vaccine Product | Office | 134 | 133 | $75.81 | $10K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 134 | 134 | $26.86 | $3,599 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 120 | 120 | $92.05 | $11K |
| 99214 Office E&M - Established | Office | 76 | 72 | $98.82 | $7,510 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 73 | 73 | $21.12 | $1,542 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 41 | 41 | $26.80 | $1,099 |
| 99203 Office E&M - New | Office | 28 | 28 | $39.97 | $1,119 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 25 | 22 | $240.64 | $6,016 |
By year: 2022 $215K for 3,847 services; 2023 $245K for 4,447 services; 2024 $254K for 4,889 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 379 | 260 | $8.65 | $3,278 |
Medicare prescription drug claims, 2024
In 2024, the drug Missak Kltchian prescribed most often to Medicare patients was Amlodipine Besylate, with 1,474 prescriptions and refills. In total Missak Kltchian wrote 29,267 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,474 | 1,692 | 169 | $1,475 |
| Rosuvastatin Calcium Generic | 1,365 | 1,548 | 155 | $4,480 |
| Losartan Potassium Generic | 1,266 | 1,482 | 152 | $2,946 |
| Atorvastatin Calcium Generic | 1,094 | 1,358 | 162 | $2,805 |
| Gabapentin Generic | 861 | 873 | 92 | $2,399 |
| Metformin Hcl Generic | 852 | 969 | 107 | $12K |
| Omeprazole Generic | 839 | 919 | 115 | $1,865 |
| Metoprolol Succinate Generic | 669 | 794 | 82 | $2,867 |
| Tamsulosin Hcl Generic | 652 | 761 | 87 | $2,012 |
| Dexlansoprazole Dr Dexlansoprazole | 607 | 622 | 78 | $98K |
| Escitalopram Oxalate Generic | 603 | 635 | 66 | $1,178 |
| Diclofenac Sodium Generic | 531 | 532 | 105 | $125K |
| Linzess Linaclotide | 514 | 522 | 62 | $271K |
| Ketoconazole Generic | 449 | 458 | 79 | $30K |
| Furosemide Generic | 442 | 501 | 60 | $552 |
Brand drugs: 4,591 claims; generic drugs: 23,924 claims; opioid claims: 385.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Missak Kltchian $1,544 ($1,544 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $210.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $210 |
| Ardelyx, Inc. ARDX | 7 | $199 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $173 |
| Shield Therapeutics Inc STX.L | 5 | $152 |
| Amgen Inc. AMGN | 8 | $151 |
| Lilly USA, LLC LLY | 4 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $91.91 |
| Aimmune Therapeutics, Inc. | 3 | $77.85 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $67.68 |
| Novo Nordisk Inc NVO | 3 | $57.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.